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Co-Existent Klinefelter's Syndrome, Acquired Cutaneous
Hepatic Porphyria and Systemic Lupus Erythematosus
M . Saeed-uz-Zafar, M.D.,* W. R. Gronewald, M.D,,=5
and G. B. Bluhm, M.D.* ' *

A patient is reported with Klinefelter's syndrome, systemic lupus
erythematosus
(SLE) and acquired cutaneous hepatic porphyria. Although patients with chromatin positive Klinefelter's syndrome may have elevated auto-antibodies, this patient
had definite diagnostic criteria for SLE. Furthermore,
evidence of disturbed
porphyrin metabolism
compatible with acquired cutaneous hepatic
porphyria
was found. It is speculated that the major disturbance in our patient's
porphyrin
biosynthesis may be distal to ^-ALA synthetase. Any association between the
three diseases is conjectural: however, it is noteworthy that both SLE and porphyria are more common in the female and that our patient had two X chromosomes in addition to a Y chromosome in his karotype.

Mayo Clinic experience of 50 patients
with Klinefelter's syndrome and listed
53 associated diseases. While two of
their cases had rheumatoid arthritis,
none had systemic lupus erythematosus
(SLE) or porphyria. However, SLE
and porphyria have also been associated and recently Harris et aF collected
six such cases. The chromosome patterns were not described.
This report describes a patient with
Klinefelter's syndrome associated with
both SLE and acquired cutaneous hepatic porphyria.

Klinefelter and co-workers^ in 1942
first reported nine males with eunuchoid habitus, gynecomastia, small
testes, aspermatogenesis, moderately
reduced function of the Leydig cells
and increased gonadotrophins. Jacobs
and Strong- and Ford et aF demonstrated in 1959 that Klinefelter's syndrome was due to an X-chromosome
polysomy. Although various other karyotype patterns have since been reported, the basic chromosomal abnormality is the supernumerary X-chromosome in at least one line of somatic
ceUs.
Co-existent with Klinefelter's syndrome, many diseases have been reported. K. L. Becker* reviewed their

Case Report
R.T., a 35-year-old press operator, was
admitted to the Henry Ford Hospital for
complaints of recurrent postprandial epigastric distress with seasonal variation for
15 years, irritation in his eyes for 10 years,
unsatisfactory sexual performance for 10
years, migratory arthralgia for six months,
and a pink urine for two months.
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A duodenal ulcer had been previously
diagnosed radiographically; it had responded to antacid and diet therapy but had recurred with ingestion of alcoholic beverages.
The patient's eyes had always been dry
and even as a child he had been unable to
produce tears. He was married at the age
of 17 and allegedly fathered a child a year
later. His second marriage has been infertile. Joint complaints started with a painful swelling of the left ankle; subsequently
involved were the right ankle, both knees,
wrists, the metacarpal-phalangeal and proximal interphalangeal joints of both hands in
a migratory, polyarticular pattern. Treatment was initiated at another hospital with
corticosteroids two months prior to his
admission here, but the joint symptoms
increased and he noticed a pink color to
his urine for the first time. His mother
had undergone many abdominal operations
but no details are available.
On physical examination, this garrulous
man was 69 inches tall and weighed 207
pounds. The skin was tanned; an acneform
eruption was present on his face. The
facial, axillary, and pubic hair were sparse.
Examination of the ears, nose and throat
was unremarkable. The optic fundi were
normal but slit-lamp examination revealed
filamentous sloughing of the corneal epitheleum. Schrimer's test indicated a deficiency of tears. The heart and lungs were
normal, but bilateral gynecomastia was
noted. The abdomen was slightly protuberant, the liver and spleen were of normal
size, and no abdominal masses were felt.
The penis and prostate were normal; however, both testes were small, measuring I1/2
cm in greatest diameter. There were effusions in the proximal interphalangeal joints
of the left fourth finger, of the third and
fourth right fingers and in the right knee.
The range of motion was normal. Neurologic examination was normal except for
borderline mental retardation.

Laboratory Data
Hemoglobin 13.5 gms%; WBC 7,200/
ccm with normal differential; reticuloyctes
1%; red blood cells were normocytic and
normochromic. BUN, serum electrolytes,
uric acid, calcium, phosphorus, blood
cholesterol, 2-hour post prandial blood
sugar, serum bilirubin, alkaline phosphatase, SGOT, and serum protein electrophoresis were normal. BSP retention was
7.5% at 45 minutes.
Urine was pink in color, with a pH of

5.0 and no sugar or albumin. Urinary delta
aminolevulinic acid (A-ALA) and porphobilinogen (PBG) were negative; but, uroporphyrin was elevated to 4.5 mgm/24
hours, and coproporphyrin was normal at
140 M.g/24 hours (Table I).
TABLE I
Precursors of Heme in Urine/24 hours
Precursors

Excretion In
Patient's Urine

Normal

Negative

1. Porphobilinogen

.Negative

2. Uroporphyrin

4.5 mg

15 meg

3. Coproporphyrin

140 meg

100- 300 meg

Endocrine studies: Protein bound iodine
(PBI), plasma Cortisol, urinary 17-OH corticosteroids and 17-ketosteroids were normal. Growth hormone suppressed normally
with exogenous glucose as against reported
inappropriate secretion of some hormones
in acute intermittent porphyria." Urinary
testosterone was low at 21.2 /ig/24 hours
(normal 40-100 /xg/24 hours for males).
Urinary gonadotrophins were elevated (positive at 96 MUU).
Chromosome analysis revealed an XXY
pattern (Fig l)."* An LE preparation was
positive with 31 and 32 LE cells on two
different occasions. ANF was positive exhibiting a strong homogeneous, strong
peripheral type pattern.f. s Differential
rheumatoid agglutination titer was negative
and serum complement titer was normal. In
a skin biopsy, the direct immunofluorescent
band test was positive for a stippled band;
the indirect test using the patient's serum
was negative.9 (Fig 2)t

Discussion
A diagnosis of Klinefelter's syndrome was suspected because of the
history of progressive impotence, infertility, gynecomastia, and small
testes. 1 It was supported by low urinary
testosterone and elevated gonadotrophins and was substantiated by an
X X Y karyotype (Fig 1). Although the
"'Kindly prepared for us by Dr. Lester
Weiss
tKindly provided by Dr. T. Burnham
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Figure 1
Karyotype of a peripheral blood cell in metaphase, prepared from the patient. The extra "X"
chromosome is paired with the normal X-chromosome between the top two rows.

porphyria was discarded because of a
negative family history and the absence
of acute abdominal attacks.
Porphyria is a metabolic disorder
characterized by increased excretion of
porphyrins and/or their precursors.
Granick" demonstrated in liver cell
cultures that chemicals which can induce porphyria will elevate the levels
of A L A synthetase. Tschudy^- demonstrated increased levels of A L A
synthetase in the livers of patients
with acute intermittent porphyria,
and Levere and Kappas^^ suggested
that a defective operator mechanism
in the gene (Fig 3) results in this
elevated level, characteristic of the
hereditary porphyrias. Furthermore,
they speculate that congenital ery-

patient claimed to have fathered a
child, a history of past fertility does
not necessarily exclude a diagnosis of
Klinefelter's syndrome."' The child and
the mother were not available for genetic studies to determine the probability
of paternity.
The diagnosis of acquired cutaneous
hepatic porphyria is supported by the
elevated uroporphyrins, and normal
PBG, A-ALA, and coproporphyrins
(Fig 3). The diagnosis of congenital
erythropoietic porphyria was discarded
because that disorder usually manifests
itself in childhood and is frequently
associated with hemolytic anemia and
splenomegaly, both being absent in our
patient. Furthermore, the possible diagnosis of congenital cutaneous hepatic
229

Zafar, Gronewald and Bluhm

Figure 2
Clinically normal skin from the patient was incubated with fluorescein conjugated goat antihuman IgG. A discontinuous stippled band is seen at the dermal-epidermal junction (arrow).
The epidermal side of the specimen is to the right.

thropoietic porphyria results from a
relative deficiency of PBG isomerase,
because in this disorder uroporphyrin
I and coproporphyrin I are produced
excessively in the circulating erythrocytes, while amounts of the type I I I
isomers are normal.
A L A synthetase activity has not been
proven to be elevated in acquired
cutaneous hepatic porphyria. Since AALA and PBG were normal in our
patient, one may speculate that the
basic defect in the biochemical pathway
is distal to A-ALA synthetase and
therefore extra mitochondrial,
It is possible to precipitate porphyria
by a number of chemical agents: Arsenic, bismuth, copper, gold, iron, lead,
silver, phosphorus, zinc, carbon tetra-

chloride; drugs: Chloroform, sulfonamides, nitroglycerine, sulfonal; and the
sex hormones or their metabolites. No
history of exposure to these substances
could be obtained in our patient. He
admitted to heavy ethanol ingestion
which may have played an etiologic
role in the development of porphyria.
However, the only evidence of hepatic
disease was the slightly elevated BSP
retention of 7.5%. To our knowledge,
an association has not been demonstrated between chromosomal abnormalities and porphyria.
The diagnosis of SLE was documented by the arthritis, the positive
LE cell tests, and a homogeneous positive ANF. It was further substantiated
by the demonstration of a stippled im230
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Figure 3
Scheme depicting the control mechanisms of heme synthesis and stages in the biosynthesis
of heme. (Adapted from Granickn and Kappasi^) The following abbreviations are used:
delta amino levulinic acid; A-ALA DH, delta amino levulinic acid dehydrogenase;
PBG, porphobilinogen; PBG D, porphobiHnogen deaminase; 750, isomerase; U.D., urogen
decarboxylase; CO, coprogen oxidase; ALA Synthetase, amino levulinic acid synthetase.
ALA synthetase is considered to be the rate limiting enzyme operating in a system with two
types of inhibition—feedback control and operon. A protein (apopressor) generated by the
regulator gene forms a complex with heme (co-repressor) which in turn represses the operator
gene. Inducers can displace heme from the heme-apopressor complex, rendering the repressor
mechanism inactive. Then, the structural gene becomes available to code more messenger RNA.
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munofluorescent anti-IgG band in the
skin biopsy.^ In the six previously reported patients' with co-existent SLE
and porphyria, four demonstrated the
LE cell phenomenon. It is noteworthy
that all of these patients were females
and that our patient had a supernumerary X chromosome.
The frequency of autoantibodies in
Klinefelter's syndrome is disputed.
While Ferguson-Smith^"' reported no

increase in the incidence of ANF,
Engleberth and co-workers^" found a
28% increase. In our patient the combination of clinical and laboratory evidence is sufficient for diagnosis of SLE.
The association of SLE and Klinefelter's syndrome has not been reported and
it is only speculative that the chromosomal abnormality in our patient predisposed to the abnormality of porphyrin metabolism.
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